Login / Register
iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
News By Market
Top PlusOneCoin Posters
Data Tools >
Price & News Alerts
More Tools >
My Image Gallery
PLUS1 Info & Faucet
Medical - Healthcare
Add ZOM Price Alert
Search This Board:
11/25/2021 2:16:48 PM
- Board type:
- Posts Today:
Zomedica Due Diligence
CEO Robert Cohen Track Record
Razer Blade System in Sales
Head of Commercialization Sales
Zomedica utilizing it's competitors knowledge.... It's nice to have a high-level person from one of Zomedica's biggest competitors on our team...
Bruk Herbst - Zomedica’s Chief Commercial Officer
1. IDEXX - Executive Director, Head of Sales and Marketing
2. Voyce - Executive, Sr. Vice President of Sales Marketing
3. CSL, Sales Consulting - Founder
(IDEXX is our main competitor in the market, check them out)
"Over the course of his dynamic career, he has successfully launched numerous veterinary products on behalf of global corporations and startup enterprises.".
Zomedica has $277.0+ Million on hand... and is set to Acquire... but who? Learn: beechwood.pro/brochure.pdf
"As part of our business strategy, we may pursue in-licenses or ACQUISITIONS of other complementary assets and business and may also pursue strategic alliances."
-10-K Earnings 2020
---Robert Cohen's (CEO) specialties include acquisitions and global expansion within industry! Even while he is acting CEO of Zomedica, he remains a Senior Advisor for Beechwood Capital Advisors.
"Beechwood's team has deep experience in commercial banking, investment banking and management consulting... ...We have managed acquisitions, mergers, divestitures, business sales and financial transactions for companies valued between $5 million and $350 million dollars.
Our Advisory Board consists of many well-known executives and recognized experts in their respective fields, including Robert Cohen, Jack Jacobs, Don Jones, and Henry DeGeneste."
1. Series 1 Shares Eliminated, opening the door to amalgamations, mergers, acquisitions etc.
2. Cohen Specializes in Acquisitions!
3. Cohen is still a Senior Advisor of Beechwood, specializing in acquisitions!
4. Cash-on hand & no debt + new revenue is a great incentive. It's like buying a car made of gold, if it doesn't run, you can still sell the gold no problemo.
5. Price volatility and extreme short interest. Hard to deny the heavy manipulation here.
6. Lack of PR. This could be to keep the price down, or it could just be because it doesn't matter if they're being bought.
7. Overly bearish sentiment for there being no bad news, and tons recent and potential good news
Qorvo owns 2,565,789 shares at $1.52
Seraph owns 641,717 shares at $1.94
Celsee owns 112,314 shares at $2.22
Previous Series 1 Shareholders:
Wickfield owns 24,719,101 shares at $1.78
Wickfield Bridge Fund LLC, previously held 12 Series 1 Preferred Shares.
Each of those shares cost them $1.0m (totaling $12.0m). They were guaranteed a return of $108.0m either through direct payment or 9% royalty of ZOM's net sales.
Instead, Wickfield Bridge Fund LLC agreed to exchange their 12 Series 1 Preferred Shares for 24,719,101 common shares at 1.78 per share, totaling ~$44.0m.
This means that Wickfield Bridge Fund LLC decided to "forfeit" $64.0m dollars of guaranteed profit in order to receive their common shares at $1.78 per share.
For Wickfield Bridge Fund LLC to "break even" the share price must reach a minimum of $4.36
H.C. Wainwright 105,013,158 shares at $1.90
"In early 2020, we successfully COMPLETED the development and manufacturing milestones for our liquid biopsy platform..... We intend to seek one or more partners for the further development and commercialization of the liquid biopsy platform."
10-K Filing, February 26th 2021
"Following the commercial launch of TRUFORMA, we expect to continue the development of another point-of-care diagnostic platform..... [ZM-020] ...... This platform is being developed with Seraph Biosciences, Inc....."
-10-K Filing, February 26th, 2021
Using the expected YoY growth rate increase from Year 2 and 3 (which was 29%) in the PCG Report, we could potentially see revenue in the billions by Year 6. The below chart is found in the June 25th PCG Research Report and only projects years 1-3.
We have no way of knowing what the actual growth rate will be. However, since years 2 & 3 were the only projected revenue [post launch] shared by Zomedica and PCG. We can use it to project at least something.. So, years 4-8 are assumed to increase in growth by 29%, just like Zomedica expected year 2-3 revenue to grow.
This is likely a low estimate, considering Zomedica's growth goals are global.
Year 1: $7,450,000
Year 2: $20,250,000
Year 3: $60,750,000.00
Year 4: $156,735,000.00
Year 5: $449,829,450.00
Year 6: $1,421,461,062.00
Year 7: $4,904,040,663.90
Year 8: $18,341,112,082.99
* ZM-024 (TRUFORMA) - PoC Biosensor Platform // Thyroid & Adrenal Disorder Immunoassays +3 additional assays + 2 more by end of year. 8 Assays in Total
* ZM-022 - Lymphoma Assay
* ZM-020 - PoC Pathogen Detection Platform // Urine & Fecal Testing
* ZM-017 - Canine Cancer Liquid Biopsy Platform // Hemangiosarcoma, Osteosarcoma & Lymphoma
* ZM-012 -Metronidazole Tablet // Anti-diarrheal - Approved for use in humans, same API as Flagyl
* ZM-011 - Transdermal Fluoxetine // Behavioral disorders, e.g. inappropriate urination, same API as Prozac
* ZM-007 - Metronidazole Oral Suspension // Anti-Diarrheal for small breeds & puppies.
* ZM-006 - Transdermal Methimazole // Hyperthyroidism - Oral formulation approved for use in humans (Tapazole) & cats (Felimazole)
Institutional Shares - 149,363,921 - 15.30%
Vanguard Holds 82,747,393
State Street Corp Holds 18,366,408
BlackRock Holds 17,325,384
Renaissance Technology Holds 13,371,960
SPDR S&P Pharmaceuticals ETF Holds 13,091,502
Cambridge Investment Holds 11,143,288
Geode Capital Management Holds 7,881,629
FSMAX Fidelity Holds 7,285,929
ProShares Pet Care ETF Holds 3,974,156
Brown Brothers Harriman Holds 2,285,532
Northern Trust Holds 2,157,655
Morgan Stanley Holds 1,990,890
Swiss National Bank Holds 1,983,700
Chase Bank Holds 1,115,014
Pinnacle Wealth Holds 1,005,022
iShare S&P Total US Market 900,203
May 2021 Was At 6.04% It Has More Then Doubled Since Then
If institutions are loading on a stock under $5 there’s a good reason behind it! TUTS don’t load on stocks under $5!
ZOM Detailed Quote
ZOM News: Current Report Filing (8-k)
11/18/2021 02:06:14 AM
ZOM News: Zomedica posts widening Q3 net loss as SG&A expenses more than double
11/12/2021 12:39:19 PM
ZOM News: Zomedica reports Q3 results
11/12/2021 11:17:23 AM
ZOM News: MSCI adds ZOM, CLOV, 110 others to US Micro Cap Index, MNKD, SAVA to be deleted
11/12/2021 09:27:16 AM
ZOM News: Statement of Changes in Beneficial Ownership (4)
11/10/2021 11:15:23 AM
Post New Msg
My Stocks (97)
$ZOM Due Diligence
09/13/21 07:35:26 AM
All you Zombies show your faces
11/25/21 02:16:48 PM
Buying opportunities .. thanks for the wishes.. cut
11/23/21 08:22:19 PM
your lower 550's have now become your lower 40's
11/23/21 02:57:58 PM
Insiders buying they know it's undervalued.
11/23/21 09:41:05 AM
Keep lurking with full pipeline Zomedica should be
11/23/21 06:06:22 AM
Keywords PIPELINE ZM-017 / ZM-020 on the way
11/23/21 06:05:19 AM
Bro he is fully retired.. he came in
11/23/21 06:04:01 AM
Insider buying board member buys 250k shares at
11/23/21 06:02:56 AM
A lot of patent news on ZM-017/ZM-020 Over
11/23/21 06:01:25 AM
Never thought it would go below.50. I nice
11/22/21 02:32:02 PM
As with any stock it always depends on
11/22/21 01:58:19 PM
I’m down 77%. $ZOM better bounce back, or
11/22/21 12:31:01 PM
Yeah, I am down 67% here myself.
11/22/21 12:21:43 PM
I guess it was a fluke to hit
11/22/21 12:15:09 PM
Eyal you are one of the best of
11/22/21 08:15:45 AM
Let see how that work out for yall..
11/21/21 05:38:24 AM
I honestly can't put a number on it
11/20/21 11:52:14 PM
Where do you see ZOM as a buy?
11/20/21 03:14:26 PM
11/19/21 12:13:12 PM
It’s on drugs! Rev is for crack heads!
11/19/21 06:13:48 AM
Yep. This one has no real revenue and
11/18/21 08:45:59 PM
Wow…. So much for 50 cent support.
11/18/21 11:53:56 AM
Let’s save these posts and check back in
11/16/21 02:14:50 PM
Keep dreaming. Zomedica is about to close
11/16/21 12:37:28 PM
I disagree with almost this entire post. This
11/16/21 10:59:42 AM
Does anyone have any insight into what $zom
11/16/21 09:22:02 AM
Stop feeding into the narrative guys and make
11/13/21 01:35:52 PM
I will drop in feb or march.
11/06/21 07:04:15 PM
I really dont care how many shares you
11/06/21 06:57:16 PM
Of course anytime man
11/05/21 08:22:47 AM
Ahhh. Thank you for that breakdown.
11/05/21 08:16:57 AM
No News and We Rise I knew this
11/05/21 03:02:32 AM
Leave those emotions in the bedroom .. Stocks
11/05/21 03:00:29 AM
Truly hate that website man.. their taking kickbacks
11/05/21 02:56:29 AM
By the wave cycle on the cart I
11/05/21 02:50:56 AM
No idea who Russell is. ATH $2.90? You
11/04/21 10:19:17 PM
Good read https://investorplace.com/2021/11/pet-stocks-alert-what-is-going-on-w
11/04/21 08:42:41 PM
Good old Russell.. I told you guys once
11/04/21 06:25:29 PM
Picking you up soon ??
11/04/21 06:24:09 PM
Good for paperhands.. I can hold 600k+ shares
11/04/21 06:23:51 PM
News with this momentum would be just what
11/04/21 05:38:26 PM
I don’t see any, so probably expect some
11/04/21 05:36:14 PM
Why is this running? Did news come out?
11/04/21 05:03:20 PM
Think what you want everything i said was
11/04/21 02:58:23 PM
Mine is $1.278
11/04/21 10:46:08 AM
What’s everyone’s Cost Average?
11/03/21 07:18:57 PM
Let’s be nice ?? .. not everyone understand
11/03/21 07:18:14 PM
Adios move on troll.
11/03/21 06:51:31 PM
you hope but i wouldnt count on it.
11/03/21 03:33:28 PM
eyal when iu needed to talk to them
11/03/21 03:32:08 PM
Post New Msg
My Stocks (97)
Get FREE PlusOneCoins!
© 2021 InvestorsHub.com, Inc.
Terms of Service
Advertise With Us
Market Vision (YouTube)
Stock Market 101
Investor Help Forum
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App